WCN25-4100 "DOUBLE TROUBLE: ANCA AND ANTI GBM DISEASE OVERLAP”: A DECADE LONG EXPERIENCE FROM A TERTIARY CARE HOSPITAL OF EASTERN INDIA

remission (81% vs 26.3%, p<0.001).At 48 months, non-diabetics had superior dialysis-free renal survival (96.3% vs 44.7%, p<0.001).After propensity score matching, renal survival remained significantly better in non-diabetics (100% vs 65.2%, p<0.001).Immunosuppression did not significantly improve renal survival in either group (83.7% vs 77%, p0.38).However, among diabetics, immunosuppression was associated with a trend towards better renal survival (61.5% vs 36%, p0.13), although this was not statistically significant.Conclusions: Diabetes mellitus, even in the absence of diabetic kidney disease, is associated with poorer renal and patient outcomes in infection-related glomerulonephritis.Despite comparable use of immunosuppressive therapy, outcomes were worse in diabetics, though immunosuppression showed a trend towards benefit in diabetic patients.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.